A B S T R A C T Correlation of leukocyte typing with homograft survival suggests that HL-A typing of white blood cells reflects the histocompatibility factors of the kidney, yet some apparently well-matched kidneys are rejected. The latter results may, in part, reflect inadequacies of typing techniques, incomplete expression of HL-A factors on white blood cells as compared with the cells of the rejected organ, or isoantigens not shared with leukocytes.
INTRODUCTION
There is little doubt as to the importance of HL-A matching of leukocytes and the success of organ transplantation, as shown by this (2) , and other laboratories (3) (4) (5) (6) (7) . Some well-matched recipients, however, have rejected kidneys, whereas other poorly-matched recipients have experienced no or only minor rejections. With the availability of kidney cells from pretransplant biopsies and the ability to maintain these cells in monolayer culture, the phenotyping of kidney cells in a routine cytotoxicity test seemed feasible as a possible means of improving donor-recipient tissue matching.
Detection of HL-A antigens in short and long term cell cultures derived from various human tissues and using several different techniques has been reported by a number of investigators (8) (9) (10) (11) . Thus far, the techniques used to phenotype kidney cells have been lengthy and complex. Most of the comparative studies of lymphocytes and kidney cells have involved the use of different techniques, varying in sensitivity, to test each cell type (12) (13) (14) (15) . The present study was undertaken in an attempt to determine whether the HL-A phenotype of kidney cells was, in fact, identical with that of the lymphocytes of the same individual, and ultimately, using post-rejection antisera, to investigate the presence and role of kidney specific antigens. The HL-A phenotypes, determined by the fluorochromasia cytotoxicity assay (16) , of lymphocytes and kidney cells from 14 individuals are reported.
METHODS

Antisera
The antisera used in this study were obtained from multiparous women and volunteer donors (immunized with human skin grafts and/or leukocytes). A minimum of 44 antisera, containing the specificities for antigens HL-A1, HL-A2, HL-A3, HL-A5, HL-A7, HL-A8, HL-A9, HL-A12, 4a, and 4b, were used. From three to eight sera of known specificity were tested for each antigen. Characterization of the cytotoxic specificities of some of these antisera has been reported previously (17) (18) (19) 
Cell preparation
Lymphocytes. Peripheral blood lymphocytes were separated from defibrinated blood and purified on nylon wool columns, as described by Bodmer, Tripp, and Bodmer (16) . Lymph nodes were excised and immediately placed in cold McCoy's medium. The nodes were refrigerated until lymphocytes could be prepared (usually within 2 hr but occasionally as long a 12 hr). The nodes were dissected free of the surrounding connective tissue and fat, were washed with Hanks' balanced salt solution and were placed on a fine mesh stainless steel screen and cut into small pieces. A blunt-ended instrument was used to free the lymphocytes from surrounding tissue; occasional rinsing with a few drops of Hanks' solution facilitated drainage of the cells through the screen. The resulting suspension was counted (counts ranged from 20 to 60 X 103/mm3 in approximately 5 ml Hanks' solution) and the appropriate dilution of lymphocytes was made (see below). The cells were then treated in the same manner as lymphocytes prepared from the peripheral blood. (2 ,l) . The plates were manually rotated for a few seconds, covered with an opaque cover, and incubated at room temperature for I hr. 4 gl of rabbit complement (Hyland Laboratories, Los Angeles, Calif.) was then added to each droplet; the plates were again rotated, covered, and incubated at room temperature for 2 hr. In addition to the nonantibody containing serum control, with which all other sera were compared, droplets of FDA treated cells plus complement and FDA treated cells alone were dispensed. As the kidney cells were more susceptible than lymphocytes to nonspecific cytotoxic effects of the rabbit complement, the cells were tested, in initial experiments, with several lots of complement. One lot was found to be less damaging to the cells than others tested, and it was used, undiluted, with both kidney cells and lymphocytes for most of the study. If other lots were used, a dilution of 1: 2 produced satisfactory results. Freshly prepared rabbit serum which was absorbed with human kidney cells was not significantly better than the commercially prepared complement. The test droplets were read and scored from 1 to 4 (16) . The readings did not change when the plates were stored in the refrigerator for several hours following the 2 hr incubation at room temperature; this, however, was not a routine procedure.
'Lymphocytes which were to be frozen, as described (16) , were resuspended to a concentration of 20 X 103/mms in Hanks-BSA containing 10%o dimethyl sulfoxide (DMSO) and were thawed and diluted to the appropriate concentration in Hanks-BSA immediately before testing. (Table I ). This somewhat lower percentage was not restricted to antisera of a given specificity but was found with almost all of the test sera in reactions with both cultured and noncultured kidney cells. No pattern of antigenic loss or gain with increasing number of subcultures or day in culture was observed in the cultured kidney cells. In general, however, culturing longer than 7-8 wk or subculturing more than nine times did not yield a sufficient number of cells for testing due to their decreased viability, a greater proportion of clumped cells, and an increased susceptibility to nonspecific lysis. Therefore, whenever possible, 2 to 6-wk cultures were harvested, and the cells were frozen in liquid nitrogen. These cells were then available for repeat testing, either immediately upon thawing or after reculturing.
Previous reports of HL-A antigens on renal cells have not included morphologic examination. In the present study, cell suspensions were examined by light and electron microscopy. The kidney cells were generally pleomorphic and varied in tinctorial properties with Wright's stain; however, they could be divided into three groups on the basis of size. Occasional multinucleate giant cells were present, and some mitotic figures were observed in the cultured cells. Preliminary electron microscopic studies 2 of the kidney cell cultures showed many of the cells to resemble early forms with prominent nucleoli and loose euchromatic nuclei. Collagen formation was not observed. To date it has not been possible to relate the varying sized cells to specific kinds of kidney cells. The inability to classify these cells, however, does not impair the ability to phenotype them with cytotoxic antisera. Cells of all sizes were labeled with the same intensity by the fluorochromatic reagent, and lost label (were killed) to an equal extent when exposed to appropriate typing sera; they retained label to an equal extent when exposd to typing sera with which they did not react.
A comparison of the lymphocyte and kidney cell phenotypes of the 14 individuals studied is shown in Table II . The over-all agreement of lymphocytes vs. kidney cells for 10 antigens was 86% based on two or more phenotypings of each cell, as indicated. Two of the 14 lymphocyte-kidney cell pairs agreed for 10/10 antigens, seven agreed for 9/10 antigens, four agreed for 8/10 antigens, and one agreed for 7/10 antigens. No significant differences were observed in comparing lymphocytes to rejected kidney or to nontransplanted kidney (Table III) ; the comparisons between lymphocytes and kidney cells are based on all of the kidney cells, irrespective of origin, except where indicated otherwise. As shown in Table  III , agreement between lymphocytes and kidney cells was 100% for antigens HL-A1, HL-A2, HL-A5, and HL-A9. Antigens which showed the greatest discrepancies were 4a, HL-A7, and HL-A8. The 4a factor was present on the lymphocytes and was not detected on the kidney cells of four individuals. HL-A7 was present on the kidney cells and not on the lymphocytes of four individuals, and HL-A8, of three. These discrepancies were found in seven different individuals, including one who was both HL-A7 lymphocyte-negative, kidney cell-positive, and HL-A8 lymphocyte-positive, kidney cell-negative.
The discrepancies between lymphocytes and kidney cells did not appear to be biased in favor of individual antisera which may be particularly strong or weak but were consistently observed with all of the antisera of a given specificity. This is illustrated in Table IV which shows the frequency of reactivity, per cent reproducibility, per cent agreement, and the discrepancies for the individual antisera of the specificities which showed the greatest disagreement between lymphocytes and kidney cells, 4a, HL-A7, and HL-A8.
DISCUSSION
The present investigation is the first comparison, to our knowledge, of human lymphocyte and kidney cell phenotypes determined in an identical cytotoxicity test system. The data presented here indicate that kidney cells can be successfully phenotyped by a routine cytotoxicity test and that, in general, the results agree well with lymphocyte phenotypes of the same individuals. However, a number of reproducible differences between the two cell types have been observed in several of the pairs tested. The 4a factor was not detected on the kidney cells of four individuals on whose lymphocytes it was present, whereas HL-A7 was found on the kidney cells of four individuals and HL-A8 on the kidney cells of three individuals on whose lymphocytes these antigens were not detected: Four of the 14 kidneys studied were from rejected renal allografts, which raises the possibility that antigens detected in the kidney cell preparation might be on invading host lymphocytes. This was fortunately eliminated from consideration by the fact that none of the antigens detected on kidney cells but not on lymphocytes of the organ donor were present on the lymphocytes of the graft recipient. Furthermore, the kidney cells of the two lymphocyte-kidney cell pairs which agreed for all 10 antigens were from rejected allografts. As all but one of the antisera of specificities 4a, HL-A7, and HL-A8 showed consistent reactivity with lymphocytes and kidney cells (Table IV) , the possibility that the observed differences result from random chance is unlikely.
Phenotyping discrepancies similar to those presented here have previously been reported in studies of cultured cells. Rogentine and Gerber (10) reported particular difficulty in assigning the antigen 4a to lymphoid cells in long term tissue culture. In a preliminary study, Williams, Rolley, and Hume (13) observed the presence of antigen 7d (HL-A8) on the cultured kidney cells of six individuals as detected by mixed agglutination and did not detect it on the lymphocytes of these individuals by cytotoxicity. HL-A8 was the most frequently observed antigen discrepancy, although they reported similar differences for the other antigens. All eight antigens for which they tested were reported as lymphocyte-negative, kidney cell-positive in at least one individual, and only a partial discrepancy at HL-A1 was reported as lymphocyte-positive, kidney cell-negative. Metzgar, Zmijewski, Seigler, and Oleinick (12), using leukoagglutination for leukocytes and mixed agglutination for kidney (two individuals) and skin (three individuals) cell typing with 20 antisera, found five instances of leukocyte-positive, tissue cell-negative, and 10 instances of leukocyte-negative, tissue cell-positive. The above two reports differ from this one primarily in the detection of many more HL-A specificities on tissue cells as compared to lymphocytes (leukocytes) than we observed. In interpreting One can rule out kidney specific antigens as an explanation for the discrepancies in typing results observed in the present study on the basis of the fact that the antisera used were produced through immunization of pregnancy, peripheral blood leukocytes, or skin grafts and would. not be expected to contain antibodies specific for kidney tissue. A difference in reactivity observed in the same test system suggests that the discrepancies are cell-related rather than test-related. Berah, Hors, and Dausset (22) and Dausset (23) are not necessarily regarded as indicating additional alleles at this sublocus. In consideration of the discrepancies which are reported here, it is of note that if all of the antigens which showed discrepancies are included in determining the phenotype of a cell donor, in no case does this result in the finding of more than two alleles within the first segregating series (HL-A1, HL-A2, HL-A3, and HL-A9) or within the second (HL-A5, HL-A7, HL-A8, and HL-A12). As one would expect the genetic expression of both cell types to be the same within the HL-A system, our findings suggest that an antigen found on either lymphocytes or kidney cells may exist on both, and that the observed discrepancy is a result of failure to detect it in one of the cell types.
The discrepant results between kidney cell and lymphocyte reactions with HL-A typing sera have also been noted in compatibility tests employing serum of the prospective recipient and both lymphocytes and kidneys cells of the prospective donor. This may reflect differential reactivity of the HL-A factors of the two kinds of cells, as noted above. On the other hand, the occurrence of a reaction with donor kidney cells but not lymphocytes might have additional significance if the prospective recipient has already rejected one kidney. It is theoretically possible that the serum of such an individual could react with isoantigens on the kidney cells which are not shared with lymphocytes. The existence of such antibodies remains to be proven, but we have found several examples of post-transplant sera reacting with the kidney cells and not with the lymphocytes of the kidney donor, both by the techniques described here and by using a 51Cr microcytotoxicity method (24) .
The differences in detection of antigens on lymphocytes and kidney cells noted in this study may have practical clinical significance in selecting donor-recipient pairs for organ transplantation. It appears to offer an approach to more complete and accurate HL-A typing and compatibility testing. Using the described techniques we have been able to phenotype both lymphocytes and kidney cells of prospective cadaver donors and to perform compatibility tests with both kinds of cells in little more time than it takes to test with lymphocytes alone (25) . Temporary storage of the cadaver kidneys in a perfusion device (26) allows time for these procedures.
